Contraline Stock

Contraline is developing the first long-lasting, reversible contraceptive for men

Sign up today and learn more about Contraline Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Contraline Stock

Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.

Funding History

July 2014$0
June 2016$680K
March 2017$2.3M
July 2018$0
September 2018$0



Nicole E. Hastings

Co-Founder & CEO

Kevin Eisenfrats


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: